{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:51:44Z","timestamp":1753890704522,"version":"3.41.2"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81522011, 81471074, 81670797"],"award-info":[{"award-number":["81522011, 81471074, 81670797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"Shanghai Jiao Tong University School of Medicine","doi-asserted-by":"publisher","award":["20161411"],"award-info":[{"award-number":["20161411"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00062","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T15:09:52Z","timestamp":1520262592000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and Physiological Characterization of Elevated Plasma Glucagon-Like Peptide-1 Levels (Hyperglipemia) in a Dipeptidyl Peptidase IV Mutation Carrier"],"prefix":"10.3389","volume":"9","author":[{"given":"Dandan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbo","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqiong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiqiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fimmu.2015.00386","article-title":"DPP4 in diabetes","volume":"6","author":"Rohrborn","year":"2015","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"E1010","DOI":"10.1152\/ajpendo.2000.278.6.E1010","article-title":"Somatostatin restrains the secretion of glucagon-like peptide-1 and 2 from isolated perfused porcine ileum","volume":"278","author":"Hansen","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B5","first-page":"E458","article-title":"Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig","volume":"271","author":"Deacon","year":"1996","journal-title":"Am J Physiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1463-1326.2011.01473.x","article-title":"Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence","volume":"14","author":"Van Genugten","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/1753-0407.12245","article-title":"Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests","volume":"7","author":"Deng","year":"2015","journal-title":"J Diabetes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2337\/db16-0877","article-title":"Rare loss-of-function variants in NPC1 predispose to human obesity","volume":"66","author":"Liu","year":"2017","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bbagen.2013.10.021","article-title":"Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK","volume":"1840","author":"Deng","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2003\/309532","article-title":"A new method of enteroscopy\u2013the double-balloon method","volume":"17","author":"Yamamoto","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","article-title":"Tissue processing and hematoxylin and eosin staining","volume":"1180","author":"Feldman","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1210\/jc.2010-2178","article-title":"Inhibition of DPP-4 with vildagliptin improved insulin secretion in response to oral as well as \u201cisoglycemic\u201d intravenous glucose without numerically changing the incretin effect in patients with type 2 diabetes","volume":"96","author":"Vardarli","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4158\/EP13176.CSUPPL","article-title":"AACE comprehensive diabetes management algorithm 2013","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2337\/dc09-1499","article-title":"Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits","volume":"33","author":"Drucker","year":"2010","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study","volume":"173","author":"Singh","year":"2013","journal-title":"JAMA Intern Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"334ra351","DOI":"10.1126\/scitranslmed.aag1805","article-title":"NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis","volume":"8","author":"Wang","year":"2016","journal-title":"Sci Transl Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1210\/jc.2011-2005","article-title":"GLP-1 and glucagon secretion from a pancreatic neuroendocrine tumor causing diabetes and hyperinsulinemic hypoglycemia","volume":"97","author":"Roberts","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"150049","DOI":"10.1530\/EDM-15-0049","article-title":"GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass","volume":"2015","author":"Guimaraes","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.1073\/pnas.120069197","article-title":"Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26","volume":"97","author":"Marguet","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cmet.2016.01.009","article-title":"Liraglutide compromises pancreatic beta cell function in a humanized mouse model","volume":"23","author":"Abdulreda","year":"2016","journal-title":"Cell Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nm.2371","article-title":"Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans","volume":"17","author":"Rodriguez-Diaz","year":"2011","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/eji.200323469","article-title":"Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen","volume":"33","author":"Yan","year":"2003","journal-title":"Eur J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.4049\/jimmunol.178.7.4632","article-title":"TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26","volume":"178","author":"Preller","year":"2007","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0002-9440(10)62266-3","article-title":"Circulating CD26 is negatively associated with inflammation in human and experimental arthritis","volume":"166","author":"Busso","year":"2005","journal-title":"Am J Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nchembio.126","article-title":"Peptidase substrates via global peptide profiling","volume":"5","author":"Tagore","year":"2009","journal-title":"Nat Chem Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.2337\/db12-1686","article-title":"Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors","volume":"62","author":"Butler","year":"2013","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(02)07952-7","article-title":"Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study","volume":"359","author":"Zander","year":"2002","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00592-008-0049-4","article-title":"Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals","volume":"46","author":"Bouchard","year":"2009","journal-title":"Acta Diabetol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/oby.2010.198","article-title":"DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity","volume":"19","author":"Turcot","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2337\/db15-1224","article-title":"Inhibition of dipeptidyl peptidase-4 impairs ventricular function and promotes cardiac fibrosis in high fat-fed diabetic mice","volume":"65","author":"Mulvihill","year":"2016","journal-title":"Diabetes"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T15:09:59Z","timestamp":1520262599000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":32,"alternative-id":["10.3389\/fendo.2018.00062"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00062","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"article-number":"62"}}